SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FINOTTI, Alessia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.790
AS - Asia 8.258
EU - Europa 5.667
SA - Sud America 1.478
AF - Africa 158
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 29.395
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.458
SG - Singapore 3.264
CN - Cina 2.670
IT - Italia 1.456
BR - Brasile 1.276
PL - Polonia 1.074
DE - Germania 808
HK - Hong Kong 780
UA - Ucraina 572
GB - Regno Unito 444
VN - Vietnam 405
TR - Turchia 383
SE - Svezia 324
RU - Federazione Russa 245
FI - Finlandia 233
ID - Indonesia 204
CA - Canada 158
FR - Francia 139
MX - Messico 137
IN - India 113
NL - Olanda 99
AR - Argentina 92
JP - Giappone 73
ZA - Sudafrica 69
BD - Bangladesh 62
ES - Italia 56
IR - Iran 51
IQ - Iraq 40
BE - Belgio 39
PK - Pakistan 35
AT - Austria 32
EC - Ecuador 30
CZ - Repubblica Ceca 29
AU - Australia 28
LT - Lituania 27
KR - Corea 22
GR - Grecia 20
MA - Marocco 19
CO - Colombia 18
EG - Egitto 18
RO - Romania 18
VE - Venezuela 18
AE - Emirati Arabi Uniti 17
CL - Cile 14
CH - Svizzera 13
PY - Paraguay 13
SA - Arabia Saudita 13
MY - Malesia 12
UZ - Uzbekistan 12
AZ - Azerbaigian 11
KE - Kenya 11
NZ - Nuova Zelanda 11
TN - Tunisia 11
IL - Israele 10
IE - Irlanda 9
JO - Giordania 9
TH - Thailandia 9
TW - Taiwan 9
UY - Uruguay 8
DZ - Algeria 6
JM - Giamaica 6
KG - Kirghizistan 6
LY - Libia 6
NP - Nepal 6
PE - Perù 6
PH - Filippine 6
DO - Repubblica Dominicana 5
LB - Libano 5
PA - Panama 5
PT - Portogallo 5
AO - Angola 3
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
DM - Dominica 3
ET - Etiopia 3
HN - Honduras 3
KW - Kuwait 3
KZ - Kazakistan 3
NI - Nicaragua 3
NO - Norvegia 3
SN - Senegal 3
YE - Yemen 3
BB - Barbados 2
CY - Cipro 2
HR - Croazia 2
KH - Cambogia 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
MM - Myanmar 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AQ - Antartide 1
Totale 29.364
Salva come PNG Salva come JPEG
Città #
Singapore 1.772
Ashburn 1.559
Woodbridge 1.127
Fairfield 1.122
Beijing 1.090
Warsaw 1.063
Chandler 775
Ann Arbor 772
Hong Kong 767
Santa Clara 762
Houston 687
Jacksonville 653
Wilmington 467
Seattle 465
Ferrara 436
Cambridge 339
Los Angeles 262
Dallas 251
Nanjing 247
New York 240
Munich 237
Izmir 226
Princeton 199
Jakarta 170
Shanghai 138
Addison 130
Boardman 128
Ho Chi Minh City 128
Bologna 113
Bremen 111
Milan 102
São Paulo 100
Redwood City 93
San Diego 88
Shenyang 85
Turku 81
Hanoi 80
Mexico City 80
London 78
Hefei 67
Brooklyn 63
Nanchang 61
Tokyo 61
Falls Church 58
Chicago 53
Rio de Janeiro 53
Denver 51
Hebei 48
Rome 48
Dong Ket 47
Moscow 47
The Dalles 47
Orem 46
Toronto 44
Dearborn 43
Stockholm 42
Changsha 41
Montreal 41
San Francisco 40
Buffalo 39
Hangzhou 39
Jiaxing 38
Johannesburg 37
Verona 37
Boston 36
Guangzhou 35
Atlanta 34
Jinan 34
Tianjin 34
Brussels 33
Mountain View 33
Chennai 32
Curitiba 31
San Jose 31
Auburn Hills 30
Norwalk 30
Poplar 30
Zhengzhou 30
Phoenix 29
Columbus 27
Amsterdam 26
Brasília 26
Helsinki 26
Frankfurt am Main 25
Washington 25
Belo Horizonte 24
Falkenstein 23
Ankara 22
Des Moines 22
Nuremberg 22
Council Bluffs 21
Manchester 21
Kunming 19
Ningbo 19
Brno 18
Parma 18
Ferrara di Monte Baldo 17
Porto Alegre 17
Vienna 17
Campinas 16
Totale 19.347
Salva come PNG Salva come JPEG
Nome #
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 384
A validated cellular biobank for β-thalassemia 364
Ground state naïve pluripotent stem cells and CRISPR/Cas9 gene correction for β-thalassemia 340
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 315
TREATMENT OF BETA-THALASSEMIA PATIENTS WITH RAPAMYCIN (SIROLIMUS): FROM PRE-CLINICAL RESERCH TO A CLINICAL TRIAL 313
A validated THALAMOSS cellular biobank for β-thalassemia 291
Transient Receptor Potential Ankyrin 1 Channels Modulate Inflammatory Response in Respiratory Cells from Patients with Cystic Fibrosis 277
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 270
Changes in hemoglobin profile reflect autologous blood transfusion misuse in sports 260
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions 247
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 246
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 241
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 232
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 229
SPR-based non-invasive prenatal testing for fetal sex determination 216
Possible detection of Autologous Blood Transfusion (ABT) based on circulating plasma microRNAs involved in erythroid differentiation and fetal hemoglobin induction 205
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system 204
Altered erythroid-related miRNA levels as a possible novel biomarker for detection of autologous blood transfusion misuse in sport 201
A peptide nucleic acid against microrna miR-145-5p enhances the expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Calu-3 Cells 200
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells 199
Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance 199
High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222 198
Isothermal circular-strand-displacement polymerization of DNA and microRNA in digital microfluidic devices 196
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA 194
A novel and efficient protocol for Surface Plasmon Resonance based detection of four β-thalassemia point mutations in blood samples and salivary swabs 194
Induction of apoptosis of human glioma cell lines: Effects of combined treatment with corilagin and temozolomide 192
Impiego di strategie di microRNA targeting combinate a trattamenti con composti di origine naturale ad attività antiproliferativa e pro-apoptotica: studio dell’effetto antitumorale in-vitro su modelli cellulari di carcinoma del colon-retto, di glioblastoma e di carcinoma mammario (NaturalMiR-Combo)” 191
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 190
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 189
Chemical-Induced Read-Through at Premature Termination Codons Determined by a Rapid Dual-Fluorescence System Based on S. cerevisiae 186
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 186
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 184
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 183
Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line 183
Epigenetic changes as a common trigger of muscle weakness in congenital myopathies 182
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 182
Regulation of IL-8 gene expression in gliomas by microRNAs 177
A liquid biopsy model: Circulating miRNA levels in mice bearing colorectal carcinoma tumor xenografts 173
Complexation to cationic microspheres of double-stranded peptide nucleic acid-DNA chimeras exhibiting decoy activity 173
AGENTI TRASFETTANTI PER ACIDI PEPTIDO-NUCLEICI 172
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 172
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 170
Regulation of IL-8 gene expression in gliomas by microRNA miR-93 167
New insights into the Shwachman-Diamond Syndrome-related haematological disorder: Hyper-activation of mTOR and STAT3 in leukocytes 167
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 166
miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma 164
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 163
Digital microfluidic devices for isothermal circular strand displacement polymerization of microRNAs 163
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 163
Antiproliferative and Erythroid Differentiation Activities of Cedrus libani Seed Extracts against K562 Human Chronic Myelogenus Leukemia Cells 161
Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression 161
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 160
Development of microRNA based protocols for detection of autologous blood transfusion in sport 158
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 156
Biological evaluation of psoralen derivatives as inhibitors of NF-κB/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression 156
Alteration of microRNA biological activity with peptide nucleic acid 155
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 155
Modulation of the Biological Activity of microRNA-210 with Peptide Nucleic Acids (PNAs) 152
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 151
PCR detection of segmented filamentous bacteria in the terminal ileum of patients with ulcerative colitis 151
miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs 150
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 150
Structural characterization of promoter sequences of the gene coding human PKI55 protein, a protein kinase C inhibitor 145
Cellular biosensors for the identification of fetal hemoglobin inducers 145
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 145
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 144
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 144
null 142
Real-time multiplex analysis of four beta-thalassemia mutations employing surface plasmon resonance and biosensor technology 141
Development and molecular characterization of transgenic mice for beta-thalassemia 140
Demonstrating specificity of bioactive peptide nucleic acids (PNAs) targeting microRNAs for practical laboratory classes of applied biochemistry and pharmacology 139
A PNA-based masking strategy for CFTR upregulation by targeting miR-145-5p binding sites of CFTR mRNA 138
Targeting microRNAs involved in human diseases: A novel approach for modification of gene expression and drug development 136
A peptide nucleic acid targeting the acpP gene of Pseudomonas aeruginosa inhibits bacterial induced biological alterations in cystic fibrosis cells 136
Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221. 135
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 134
Identification of a novel DNase I hypersensitive site within the far upstream region of the human HLA-DRA gene 134
Efficient Delivery of MicroRNA and AntimiRNA Molecules Using an Argininocalix[4]arene Macrocycle 134
A peptide nucleic acid (PNA) masking the miR-145-5p binding site of the 3’UTR of the cystic fibrosis transmembrane conductance regulator (CFTR) mRNA enhances CFTR expression in Calu-3 cells 133
Recent trends for novel options in experimental biological therapy of β-thalassemia 132
Bovine serum amine oxidase and spermine cause apoptosis in cancer cells detected by flow cytometry, real time RT-PCR and proteomic analyses 132
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients 130
AGENTI TRASFETTANTI PER microRNA E antagomiRNA 130
Non-invasive Prenatal Testing Using Fetal DNA 130
509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis 129
Involvement of miRNA in erythroid differentiation 129
Efficient cell penetration and delivery of peptide nucleic acids by an argininocalix[4]arene 129
Synergistic effects of the combined treatment of U251 and T98G glioma cells with an anti-tubulin tetrahydrothieno[2,3-c]pyridine derivative and a peptide nucleic acid targeting miR-221-3p 129
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 127
Invitro evaluation of the anti-proliferative activities of the wood essential oils of three Cedrus species against K562 human chronic myelogenous leukaemia cells 127
Transcription factors (TFs) negatively regulating gamma-globin gene transcription: BCL11A is down-regulated during mithramycin induction of erythroid cells from beta-thalassemia patients 127
Synthesis and biological evaluation of new antitubulin agents containing 2-(30,40,50-trimethoxyanilino)-3,6-disubstituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine Scaffold 127
Pro‑apoptotic activity of novel synthetic isoxazole derivatives exhibiting inhibitory activity against tumor cell growth in vitro 127
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 126
Analysis of the miRNome as a possible tool for the detection of autologous blood transfusion misuse in sport 126
Expression of miR-93 and IL-8 During Pseudomonas aeruginosa Mediated Induction of Pro-Inflammatory Responses 125
Antiproliferative and erythroid differentiation of piperazine and triphenyl derivatives against k-562 human chronic myelogenous leukemia. 125
Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review) 125
Liquid biopsy in mice bearing colorectal carcinoma xenografts: gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA) 125
Acidi peptido-nucleici (PNA) per il Genome Editing in β-talassemia: correzione sito-specifica della mutazione β°39 124
Totale 17.515
Salva come PNG Salva come JPEG
Categoria #
all - tutte 147.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.215
Totale 152.268
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.318 0 0 0 0 0 295 283 313 139 480 514 294
2021/20222.113 226 179 129 93 138 107 141 96 95 170 182 557
2022/20231.959 230 191 41 240 322 224 125 179 205 16 106 80
2023/20241.494 84 182 63 42 188 251 121 86 24 28 75 350
2024/20255.554 181 152 495 289 598 431 205 234 934 697 720 618
2025/20267.962 1.505 631 1.169 1.827 2.245 585 0 0 0 0 0 0
Totale 30.042